New GE image technique improves small lesion detection
GE Healthcare introduced at SNM 2007 in Washington, D.C., this week, a new application for performing PET image generation. VUE Point, available on the Discovery Dimension with new installations or by Continuum field upgrades for the installed base of Discovery ST systems, can help improve small lesion detectability, clinical confidence and exam productivity. Clinicians can perform advanced PET image generation to improve both qualitative and quantitative accuracy.

“It will become increasingly important to improve the quantitative performance of PET/CT for the measurement of response to therapy,” said Hadi Moufarrej, general manager of GE Healthcare’s Global Molecular Imaging Business. “This new release of VUE Point is another example of GE’s commitment to help enable the earlier detection and monitoring of disease with advanced molecular imaging technology, in both hardware and software.”

VUE Point incorporates advanced proprietary image reconstruction algorithms, including volume scatter correction and a patented image projection technique developed at GE’s Global Research facility, and is enabled by the Volume CT reconstruction technology development.  VUE Point is applicable to both 2D and 3D PET acquisition modes, static, dynamic and motion imaging.

When combined with the workflow efficiency of Discovery Dimension, VUE Point allows high-definition PET image generation on every patient exam and encompasses the full range of clinical care applications and patient size.  The technology now makes it possible for clinicians to perform advanced image generation in a routine clinical setting.